Embolization Particle Market

Embolization Particle or embolisation refers to the passage and lodging of an embolus within the bloodstream. It may be pathological (in which sense it is also called embolism), for example a pulmonary embolism, or therapeutic, as a hemostatic treatment for bleeding or as a treatment for some types of cancer by deliberately blocking blood vessels to starve the tumor cells.
Embolization Particle Market aims to provide a comprehensive presentation of the global market for Embolization Particle, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Embolization Particle. Embolization Particle Market contains market size and forecasts of Embolization Particle in global, including the following market information:
Global Embolization Particle Market Revenue, 2018-2023, 2024-2029, ($ millions)
Global Embolization Particle Market Sales, 2018-2023, 2024-2029, (K Units)
Global top five Embolization Particle companies in 2022 (%)
The global Embolization Particle market was valued at US$ 2071 million in 2022 and is projected to reach US$ 5142.9 million by 2029, at a CAGR of 13.9% during the forecast period. The influence of COVID-19 and the Russia-Ukraine War were considered while estimating market sizes.
North America is the largest region of Embolization Particle, with a market share about 40%. It was followed by Europe with 30%. Sirtex Medical, Merit Medical, Cook Medical, BTG Medical and Boston Scientific Corporation are the top 5 manufacturers of industry, and they had about 80% combined market share.
We surveyed the Embolization Particle manufacturers, suppliers, distributors and industry experts on this industry, involving the sales, revenue, demand, price change, product type, recent development and plan, industry trends, drivers, challenges, obstacles, and potential risks.
Total Market by Segment:
Global Embolization Particle Market, by Type, 2018-2023, 2024-2029 ($ Millions) & (K Units)
Global Embolization Particle Market Segment Percentages, by Type, 2022 (%)
Microspheres
Particles (e.g. PVA Particles, Gelfoam Particles)
Drug-eluting Beads (DEBs)
Radio-Embolic Microspheres (e.g. Therasphere and SIRSphere)
Global Embolization Particle Market, by Application, 2018-2023, 2024-2029 ($ Millions) & (K Units)
Global Embolization Particle Market Segment Percentages, by Application, 2022 (%)
Uterine Fibroid Embolization
Prostatic Artery Embolization (treatment for Benign Prostatic Hyperplasia or BPH)
Liver Tumor Embolization
Trauma Embolization
Others
Global Embolization Particle Market, By Region and Country, 2018-2023, 2024-2029 ($ Millions) & (K Units)
Global Embolization Particle Market Segment Percentages, By Region and Country, 2022 (%)
North America
US
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Benelux
Rest of Europe
Asia
China
Japan
South Korea
Southeast Asia
India
Rest of Asia
South America
Brazil
Argentina
Rest of South America
Middle East & Africa
Turkey
Israel
Saudi Arabia
UAE
Rest of Middle East & Africa
Competitor Analysis
The report also provides analysis of leading market participants including:
Key companies Embolization Particle revenues in global market, 2018-2023 (Estimated), ($ millions)
Key companies Embolization Particle revenues share in global market, 2022 (%)
Key companies Embolization Particle sales in global market, 2018-2023 (Estimated), (K Units)
Key companies Embolization Particle sales share in global market, 2022 (%)
Further, the report presents profiles of competitors in the market, key players include:
Sirtex Medical
Merit Medical
Cook Medical
BTG Medical
Boston Scientific Corporation
Terumo Corporation
HENGRUI Medical
INterface BIOmaterials B.V.
Alicon
Outline of Major Chapters:
Chapter 1: Introduces the definition of Embolization Particle, market overview.
Chapter 2: Global Embolization Particle market size in revenue and volume.
Chapter 3: Detailed analysis of Embolization Particle manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Sales of Embolization Particle in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space of each country in the world.
Chapter 7: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 8: Global Embolization Particle capacity by region & country.
Chapter 9: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 10: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 11: The main points and conclusions of the report.